West Jefferson, OH – According to filings with the U.S. Securities and Exchange Commission, AmplifyBio is raising $100,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, J. Kelly Ganjei played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About AmplifyBio

Amplifybio combines the strength, knowledge and experience of our partners, and the expertise of our cross-integrated teams to advance translational science, cell and gene therapies and next-generation medicines for the benefit of millions of people around the world. Our facilities include a state-of-the-art fully functional GLP lab with 200,000 sq of space dedicated to drug development including a full complement of pre-clinical models and support services.

To learn more about AmplifyBio, visit http://www.amplify-bio.com/

Contact:
J. Kelly Ganjei, President and Chief Executive Officer
833-641-2006
https://www.linkedin.com/in/kganjei/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved